Patents

US 12714686 B2: N-propargylglycine: a unique inhibitor of proline dehydrogenase with brain-enhancing mitohormesis properties capable of mitigating the pathogenesis of neurodegenerative disorders

Granted
2026-08-25
Filed
2021-10-27 application 18250721
Type
Utility · 46 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

In certain embodiments, methods of activating the mitochondrial unfolded protein response (UPRmt) and inducing mitohormesis in the brain and/or central nervous system of a mammal are provided where the methods can involve administering to the mammal an effective amount of N-proparglyglycine (N-PPG). In certain embodiments, the mammal is a mammal with a neurodegenerative disease and the method provides for the treatment or prophylaxis of the neurodegenerative disease.

Source: PTBLXML, file of 2026-08-25 (ipgb20260825.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Buck Institute for Research on Aging 52 patentsUS company or organizationNovato, CABUCK INSTITUTE FOR RESEARCH ON AGING Nonprofit EXACT high confidence: identical full name and statePTBLXML, file of 2026-08-25

Inventors

InventorPlacePatentsPerson pageSource
Gary K. ScottBerkeley, CA4PTBLXML, file of 2026-08-25
Christopher C. BenzPetaluma, CA3PTBLXML, file of 2026-08-25
Lisa M. EllerbySan Anselmo, CA4PTBLXML, file of 2026-08-25

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/197PTBLXML, file of 2026-08-25
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/28PTBLXML, file of 2026-08-25

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-12-23Other
License
BUCK INSTITUTE FOR RESEARCH ON AGING signed 2025-12-08NATIONAL INSTITUTES OF HEALTH BETHESDA, MD74049/511PASDL, file of 2026-10-08

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.